Tumor fluoro-2-deoxy-d-glucose avidity on positron emission tomographic scan predicts mortality in patients with early-stage pure and mixed bronchioloalveolar carcinoma

Journal of Thoracic and Cardiovascular Surgery

Volumn 132, Issue 5, 2006, Pages 1189-1195

  Raz, Dan J ^a   Odisho, Anobel Y ^a   Franc, Benjamin L ^b   Jablons, David M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

AGED; ARTICLE; BINDING AFFINITY; CANCER MORTALITY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG UPTAKE; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN TISSUE; LUNG ALVEOLUS CELL CARCINOMA; LYMPH NODE METASTASIS; MALE; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; TUMOR VOLUME;

ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; AGED; AGED, 80 AND OVER; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PNEUMONECTOMY; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; SURVIVAL ANALYSIS;

EID: 33750075458     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2006.06.033     Document Type: Article

References (28)

1. Carretta A., Canneto B., Calori G., Ceresoli G.L., Campagnoli E., Arrigoni G., et al. Evaluation of radiological and pathological prognostic factors in surgically-treated patients with bronchoalveolar carcinoma. Eur J Cardiothorac Surg 20 (2001) 367-371
2. Dumont P., Gasser B., Rouge C., Massard G., and Wihlm J.M. Bronchoalveolar carcinoma: histopathologic study of evolution in a series of 105 surgically treated patients. Chest 113 (1998) 391-395
3. Liu Y.Y., Chen Y.M., Huang M.H., and Perng R.P. Prognosis and recurrent patterns in bronchioloalveolar carcinoma. Chest 118 (2000) 940-947
4. Miller V.A., Kris M.G., Shah N., Patel J., Azzoli C., Gomez J., et al. Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancer. J Clin Oncol 22 (2004) 1103-1109
5. Furak J., Trojan I., Szoke T., Tiszlavicz L., Morvay Z., Eller J., et al. Bronchioloalveolar lung cancer: occurrence, surgical treatment and survival. Eur J Cardiothorac Surg 23 (2003) 818-823
6. Kitamura H., Kameda Y., Ito T., and Hayashi H. Atypical adenomatous hyperplasia of the lung. Implications for the pathogenesis of peripheral lung adenocarcinoma. Am J Clin Pathol 111 (1999) 610-622
7. Auerbach O., and Garfinkel L. The changing pattern of lung carcinoma. Cancer 68 (1991) 1973-1977
8. Barkley J.E., and Green M.R. Bronchioloalveolar carcinoma. J Clin Oncol 14 (1996) 2377-2386
9. Read W.L., Page N.C., Tierney R.M., Piccirillo J.F., and Govindan R. The epidemiology of bronchioloalveolar carcinoma over the past two decades: analysis of the SEER database. Lung Cancer 45 (2004) 137-142
10. Terasaki H., Niki T., Matsuno Y., Yamada T., Maeshima A., Asamura H., et al. Lung adenocarcinoma with mixed bronchioloalveolar and invasive components: clinicopathological features, subclassification by extent of invasive foci, and immunohistochemical characterization. Am J Surg Pathol 27 (2003) 937-951
11. Dunagan D., Chin Jr. R., McCain T., Case L., Harkness B., Oaks T., et al. Staging by positron emission tomography predicts survival in patients with non-small cell lung cancer. Chest 119 (2001) 333-339
12. Cerfolio R.J., Bryant A.S., Ohja B., and Bartolucci A.A. The maximum standardized uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence, and survival. J Thorac Cardiovasc Surg 130 (2005) 151-159
13. Downey R.J., Akhurst T., Gonen M., Vincent A., Bains M.S., Larson S., et al. Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection. J Clin Oncol 22 (2004) 3255-3260
14. Higashi K., Ueda Y., Arisaka Y., Sakuma T., Nambu Y., Oguchi M., et al. 18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer. J Nucl Med 43 (2002) 39-45
15. Jeong H.J., Min J.J., Park J.M., Chung J.K., Kim B.T., Jeong J.M., et al. Determination of the prognostic value of [(18)F]fluorodeoxyglucose uptake by using positron emission tomography in patients with non-small cell lung cancer. Nucl Med Commun 23 (2002) 865-870
16. Vansteenkiste J.F., Stroobants S.G., Dupont P.J., De Leyn P.R., Verbeken E.K., Deneffe G.J., et al., Leuven Lung Cancer Group. Prognostic importance of the standardized uptake value on (18)F-fluoro-2-deoxy-glucose-positron emission tomography scan in non-small-cell lung cancer: an analysis of 125 cases. J Clin Oncol 17 (1999) 3201-3206
17. Heyneman L.E., and Patz E.F. PET imaging in patients with bronchioloalveolar cell carcinoma. Lung Cancer 38 (2002) 261-266
18. Higashi K., Ueda Y., Seki H., Yuasa K., Oguchi M., Noguchi T., et al. Fluorine-18-FDG PET imaging is negative in bronchioloalveolar lung carcinoma. J Nucl Med 39 (1998) 1016-1020
19. Yap C.S., Schiepers C., Fishbein M.C., Phelps M.E., and Czernin J. FDG-PET imaging in lung cancer: how sensitive is it for bronchioloalveolar carcinoma?. Eur J Nucl Med Mol Imaging 29 (2002) 1166-1173
20. Detterbeck F.C., Vansteenkiste J.F., Morris D.E., Dooms C.A., Khandani A.H., and Socinski M.A. Seeking a home for a PET, part 3: emerging applications of positron emission tomography imaging in the management of patients with lung cancer. Chest 126 (2004) 1656-1666
21. Ebright M.I., Zakowski M.F., Martin J., Venkatraman E.S., Miller V.A., Bains M.S., et al. Clinical pattern and pathologic stage but not histologic features predict outcome for bronchioloalveolar carcinoma. Ann Thorac Surg 74 (2002) 1640-1646 discussion 6-7
22. Lin D.M., Ma Y., Zheng S., Liu X.Y., Zou S.M., and Wei W.Q. Prognostic value of bronchioloalveolar carcinoma component in lung adenocarcinoma. Histol Histopathol 21 (2006) 627-632
23. Noguchi M., Morikawa A., Kawasaki M., Matsuno Y., Yamada T., Hirohashi S., et al. Small adenocarcinoma of the lung. Histologic characteristics and prognosis. Cancer 75 (1995) 2844-2852
24. Sakurai H., Maeshima A., Watanabe S., Suzuki K., Tsuchiya R., Maeshima A.M., et al. Grade of stromal invasion in small adenocarcinoma of the lung: histopathological minimal invasion and prognosis. Am J Surg Pathol 28 (2004) 198-206
25. Travis W.D., Garg K., Franklin W.A., Wistuba I.I., Sabloff B., Noguchi M., et al. Evolving concepts in the pathology and computed tomography imaging of lung adenocarcinoma and bronchioloalveolar carcinoma. J Clin Oncol 23 (2005) 3279-3287
26. Raz D.J., He B., Rosell R., and Jablons D.M. Current concepts in bronchioloalveolar carcinoma biology. Clin Cancer Res 12 (2006) 3698-3704
27. Barlesi F., Doddoli C., Gimenez C., Chetaille B., Giudicelli R., Fuentes P., et al. Bronchioloalveolar carcinoma: myths and realities in the surgical management. Eur J Cardiothorac Surg 24 (2003) 159-164
28. Roberts P.F., Straznicka M., Lara P.N., Lau D.H., Follette D.M., Gandara D.R., et al. Resection of multifocal non-small cell lung cancer when the bronchioloalveolar subtype is involved. J Thorac Cardiovasc Surg 126 (2003) 1597-1602